English 
Français 
Русский 
Español 
Deutsch 
Português 
العربية 
Italiano In the rapidly evolving world of medical diagnostics, CBC analyzers stand as essential instruments in clinical laboratories worldwide. Complete Blood Count (CBC) testing remains one of the most frequently ordered blood tests, making reliable and efficient analyzing equipment crucial for healthcare delivery. Enter Ozelle, a pioneering global manufacturer redefining the standards of automated blood diagnostics through cutting-edge artificial intelligence and cell morphology analysis.
Founded in Silicon Valley in 2014 and headquartered in Frankfurt, Germany since 2020, Ozelle has established itself as a transformative force in diagnostic innovation. With over 500 employees, including substantial research and development teams across three international centers, the company has successfully deployed more than 50,000 units worldwide, providing diagnostics for over 40 million patients.
The Evolution of CBC Analysis
Understanding modern CBC analyzer technology requires appreciation for the historical progression of blood analysis methods. The journey spans from manual microscopy techniques introduced in 1852, through impedance methods developed in the 1950s, to flow cytometry innovations of the 1970s. Today’s most advanced systems, including Ozelle’s offerings, leverage artificial intelligence combined with cell morphology analysis—a paradigm shift that began in 2017.
Ozelle’s proprietary AI algorithms were recognized at the 2022 World Artificial Intelligence Conference (WAIC), representing a milestone validation of their technology trained on 40 million clinical samples.
Ozelle’s Core Strength: AI-Powered Cell Morphology
At the heart of Ozelle’s CBC analyzer lineup lies a sophisticated technology stack combining three critical components:
Advanced Machine Vision: Utilizing SwissOptic® customized lenses with 4-megapixel resolution and 50 frames-per-second capture capability, Ozelle’s systems provide unprecedented cellular clarity.
Deep Learning Algorithms: Based on training data from 40 million samples, the company’s “Expert Brain” enables precise recognition and classification of blood cells, including abnormal formations previously requiring manual expert review.
Automated Cell Identification: The system can identify and classify complex blood cell types, including morphological abnormalities such as NST (immature neutrophils), NSG (giant neutrophils), NSH (hypersegmented neutrophils), and RET (reticulocytes).
This technological foundation distinguishes Ozelle from traditional CBC analyzer manufacturers relying on outdated impedance or flow cytometry methods alone.
Ozelle’s CBC Analyzer Product Portfolio
Ozelle manufactures four primary analyzer systems, each tailored to specific clinical and veterinary applications:
EHBT-75: 7-Differential Professional Hematology Analyzer
Designed for: Advanced clinical settings requiring maximum diagnostic precision
Key Features:
-
Completely automated sample processing (collection to report generation)
-
Results delivered in just 6 minutes
-
7-part differential analysis with abnormal cell detection
-
Single-use, room-temperature-stable cartridges
-
Liquid-based staining technology for superior image quality
-
Compact, bedside-ready design
Applications: Tertiary care hospitals, specialized hematology departments, prenatal diagnostic centers
EHBT-50: All-in-One Multi-Functional Analyzer
Designed for: Comprehensive diagnostic environments requiring multiple testing modalities
Key Features:
-
7-part differential hematology analysis
-
Immunofluorescence assay capabilities
-
Dry chemistry biochemistry testing
-
Urine and fecal analysis
-
37 parameters per test
-
10.1-inch touchscreen display
-
Multi-sample processing channels
Specifications:
-
Throughput: 10 samples/hour
-
Sample volume: 30µL for testing, 60µL for loading
-
LIS/HIS integration via multiple communication ports
Applications: General hospitals, third-party diagnostic laboratories, health screening centers, medical institutions requiring integrated multi-analyte solutions
EHBT-25: 3-Part Entry-Level Hematology Analyzer
Designed for: Primary healthcare facilities and resource-limited settings
Key Features:
-
Portable design (8.1kg weight)
-
3-part differential blood analysis
-
21 core parameters
-
Individual test kit design (maintenance-free operation)
-
AI algorithm trained on 40 million samples despite compact size
-
Simple 4-step operation procedure
-
Room-temperature reagent storage
Specifications:
-
Throughput: 12 samples/hour
-
Dimensions: 360mm × 290mm × 400mm
-
Optional thermal printer compatibility
Applications: Community health centers, rural clinics, township hospitals, maternal and child health facilities, mobile diagnostic units
EHVT-50: Veterinary Multi-Functional Analyzer
Designed for: Animal healthcare providers requiring species-specific diagnostics
Key Features:
-
7-part differential hematology analysis
-
Species-specific disease marker detection (FeLV Ag, FIV Ab, etc.)
-
Urine, fecal, and immunoassay testing capabilities
-
38 total parameters
-
Support for canine and feline species with customization options
-
Veterinary-optimized quality control systems
Applications: Veterinary clinics, animal hospitals, diagnostic laboratories, research institutions, wildlife health programs
Technology Advantages Setting Ozelle Apart
Maintenance-Free Operation
Unlike traditional analyzers requiring daily maintenance, calibration routines, and reagent management, Ozelle’s systems utilize single-use cartridges and dry-chemical systems eliminating cross-contamination risks and downtime.
Comprehensive Abnormality Detection
The advanced cell morphology approach enables detection of rare and abnormal cells that traditional methods might miss, providing clinicians with actionable diagnostic insights for complex cases.
Integration and Connectivity
All Ozelle analyzers feature modern connectivity including LIS/HIS integration, USB, Ethernet, WiFi, and Bluetooth capabilities, facilitating seamless data management in networked healthcare environments.
Diagnostic Accuracy
Precision validation studies demonstrate correlation coefficients (R²) exceeding 0.99 across all major blood parameters (WBC, RBC, HGB, PLT), meeting and exceeding laboratory standards.
Global Certifications and Quality Standards
Ozelle maintains comprehensive regulatory approvals including:
-
CE certification (European conformity)
-
FDA approval (U.S. market)
-
ISO 13485:2016 (Medical device quality management)
-
ISO certification
-
CQC certification (Chinese quality)
-
Over 500 patents protecting proprietary innovations
Market Positioning and Customer Applications
Ozelle serves diverse customer segments across geographic markets:
Healthcare Segments:
-
General hospitals and specialty care centers
-
Diagnostic and reference laboratories
-
Point-of-care testing environments
-
Occupational health clinics
-
Emergency departments
Veterinary Segments:
-
Companion animal hospitals
-
Large animal veterinary practices
-
Zoo and wildlife medicine centers
-
Diagnostic laboratories
Geographic Reach:
-
Europe
-
Southeast Asia
-
Africa
-
South America
-
North America
-
Russia
Ozelle’s Comprehensive Service Model
Manufacturing cutting-edge equipment represents only one dimension of Ozelle’s value proposition. The company provides integrated lifecycle support including:
-
Installation and Operator Training: Comprehensive onboarding ensuring proper equipment utilization
-
Reagent and Consumable Supply: Reliable cartridge and supply chain management
-
Remote Technical Support: Real-time troubleshooting and consultation
-
Software Updates and OTA Capabilities: Algorithm improvements and feature enhancements via over-the-air deployment
-
Quality Assurance: Certification assistance and regulatory support
-
Equipment Optimization: Ongoing performance monitoring and customization
The Future of Blood Diagnostics
As healthcare systems worldwide increasingly emphasize point-of-care testing, cost efficiency, and diagnostic automation, manufacturers like Ozelle are positioned at the forefront of industry transformation. The integration of artificial intelligence with cellular imaging technology represents the next generation of laboratory diagnostics—moving beyond simple cell counting to comprehensive morphological analysis.
The growing demand for automated solutions in primary healthcare, coupled with rising diagnostic standards in emerging markets, creates substantial opportunities for manufacturers offering maintenance-free, user-friendly, and highly accurate systems.
Conclusion
Ozelle represents a new category of CBC analyzer manufacturer—one combining Silicon Valley innovation with German precision engineering and backed by substantial AI research and development. Whether addressing the needs of sophisticated tertiary care hospitals, resource-limited clinics, or specialized veterinary practices, Ozelle’s diversified product portfolio demonstrates how technological advancement and customer-focused design converge to reshape diagnostic medicine.
The company’s achievement—50,000 units deployed serving 40 million patients worldwide—validates both the quality of its technology and the market’s readiness for AI-powered diagnostic solutions. As blood testing remains fundamental to modern medicine, Ozelle’s innovations in cell morphology analysis, maintenance-free operation, and integrated multi-parameter testing position the company as a significant force shaping the future of diagnostic science.
For healthcare providers evaluating CBC analyzer solutions, Ozelle’s comprehensive portfolio—from entry-level portable devices to comprehensive multi-functional platforms—offers proven performance backed by advanced technology and robust global support infrastructure.
